RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      유방암의 보완대체의학적 치료에 관한 연구 = Systemic Review on Complementary and Alternative Medicine for Breast Cancer

      한글로보기

      https://www.riss.kr/link?id=A60042710

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      참고문헌 (Reference)

      1 정의민, "중의학 논문에 나타난 유방암의 연구 동향에 대한 고찰 - 중의학 논문을 중심으로 -" 대한한방부인과학회 22 (22): 263-278, 2009

      2 송희완, "종합병원에 입원한 암 환자들의 보완대체의학의 사용" 7 : 37-60, 2007

      3 김혜영, "유방암 생존자의 삶의 질, 성기능 및 우울: 성생활 집단과 비성생활 집단 간의 비교" 대한종양간호학회 8 (8): 77-85, 2008

      4 김영구, "비뇨기계 질환의 보완대체 치료" 7 (7): 6-10, 2002

      5 Gray RE, "Utilization of complementary /alternative services by women with breast cancer" 16 (16): 75-84, 2003

      6 Ashikaga T, "Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians" 10 (10): 542-548, 2002

      7 Boon H, "Use of complementary/ alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions" 18 (18): 2501-2504, 2000

      8 Nagel G, "Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey" 12 (12): 789-796, 2004

      9 Cui Y, "Use of complementary and alternative medicine by chinese women with breast cancer" 86 (86): 89-, 2004

      10 Schönekaes K, "Use of complementary /alternative therapy methods by patients with breast cancer" 10 (10): 304-308, 2003

      1 정의민, "중의학 논문에 나타난 유방암의 연구 동향에 대한 고찰 - 중의학 논문을 중심으로 -" 대한한방부인과학회 22 (22): 263-278, 2009

      2 송희완, "종합병원에 입원한 암 환자들의 보완대체의학의 사용" 7 : 37-60, 2007

      3 김혜영, "유방암 생존자의 삶의 질, 성기능 및 우울: 성생활 집단과 비성생활 집단 간의 비교" 대한종양간호학회 8 (8): 77-85, 2008

      4 김영구, "비뇨기계 질환의 보완대체 치료" 7 (7): 6-10, 2002

      5 Gray RE, "Utilization of complementary /alternative services by women with breast cancer" 16 (16): 75-84, 2003

      6 Ashikaga T, "Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians" 10 (10): 542-548, 2002

      7 Boon H, "Use of complementary/ alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions" 18 (18): 2501-2504, 2000

      8 Nagel G, "Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey" 12 (12): 789-796, 2004

      9 Cui Y, "Use of complementary and alternative medicine by chinese women with breast cancer" 86 (86): 89-, 2004

      10 Schönekaes K, "Use of complementary /alternative therapy methods by patients with breast cancer" 10 (10): 304-308, 2003

      11 Malik IA, "Use of CAM results in delay in seeking medical advice for breast cancer" 18 (18): 817-822, 2003

      12 Boon HS, "Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005" BMC Womens Health 7-, 2007

      13 Helyer LK, "The use of complementary and alternative medicines among patients with locally advanced breast cancer-a descriptive study" 6 : 39-, 2006

      14 Chen Z, "The use of complementary and alternative medicine among Chinese women with breast cancer" 14 (14): 1049-1055, 2008

      15 Einbond LS, "The growth inhibitory effect of actein on human breast cancer cells is associated with activation of stress response pathways" 121 (121): 2073-2083, 2007

      16 Kang JX, "The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells" 26 (26): 1934-1939, 2005

      17 Targ EF, "The efficacy of a mind-body-spirit group for women with breast cancer: a randomized controlled trial" 24 (24): 238-248, 2002

      18 Wang W, "The effects of herb lithospermum extract on MCF-7 cell and estrogen and progestogen levels in mice" 28 (28): 1062-1067, 2003

      19 Nizamutdinova IT, "Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells" 33 (33): 485-491, 2008

      20 R. Brown, "Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis" 248 (248): 137-146, 2007

      21 Lengacher CA, "Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer" 33 (33): 97-104, 2006

      22 Deng G, "Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients" 25 (25): 5584-5590, 2007

      23 Nedstrand E, "Psychological well-being improves in women with breast cancer after treatment with applied relaxation or electro-acupuncture for vasomotor symptom" 27 (27): 193-199, 2006

      24 Harris PF, "Prevalence and treatment of menopausal symptoms among breast cancer survivors" 23 (23): 501-509, 2002

      25 Field KM, "Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer" 45 (45): 551-560, 2009

      26 Lee JC, "Plant-originated glycoprotein, G-120, inhibits the growth of MCF-7 cells and induces their apoptosis" 43 (43): 961-968, 2005

      27 Crew KD, "Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients" 1 (1): 283-291, 2007

      28 Roberts CS, "Patient-physician communication regarding use of complementary therapies during cancer treatment" 23 (23): 35-60, 2005

      29 Yap SP, "Molecular and pharmacodynamic properties of estrogenic extracts from the traditional Chinese medicinal herb, Epimedium" 113 (113): 218-224, 2007

      30 Frisk J, "Long-term follow-up of acupuncture and hormone therapy on hot flushes in women with breast cancer: a prospective, randomized, controlled multicenter trial" 11 (11): 166-174, 2008

      31 Nangia-Makker P, "Inhibition of breast tumor growth and angiogenesis by a medicinal herb: Ocimum gratissimum" 121 (121): 884-894, 2007

      32 Mills E, "Health food store recommendations: implications for breast cancer patients" 5 (5): 300-302, 2003

      33 Jiang J, "Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling" 29 (29): 695-703, 2006

      34 Jenner C, "Galactorrhoea following acupuncture" 20 (20): 107-108, 2002

      35 Lengacher CA, "Frequency of use of complementary and alternative medicine in women with breast cancer" 29 (29): 1445-1452, 2002

      36 Myers CD, "Familial and perceived risk of breast cancer in relation to use of complementary medicine" 17 (17): 1527-1534, 2008

      37 Chiu LC, "Ethyl acetate extract of Patrinia scabiosaefolia downregulates anti-apoptotic Bcl-2/Bcl-X(L) expression, and induces apoptosis in human breast carcinoma MCF-7 cells independent of caspase-9 activation" 105 (105): 263-268, 2006

      38 Shen J, "Electroacupuncture for control of myeloablative chemotherapy -induced emesis: A randomized controlled trial" 284 (284): 2755-2761, 2006

      39 Gumus AB, "Effects of emotional support-focused nursing interventions on the psychosocial adjustment of breast cancer patients" 9 (9): 691-697, 2008

      40 Gardani G, "Effect of acupressure on nausea and vomiting induced by chemotherapy in cancer patients" 97 (97): 391-394, 2006

      41 Walker G, "Ear acupuncture for hot flushes--the perceptions of women with breast cancer" 13 (13): 250-207, 2007

      42 Saxe GA, "Disclosure to physicians of CAM use by breast cancer patients: findings from the Women's Healthy Eating and Living Study" 7 (7): 122-129, 2008

      43 Hsieh TC, "Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens" 337 (337): 224-231, 2005

      44 Lengacher CA, "Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer" 30 (30): 811-821, 2003

      45 Tao J, "Cytotoxicity of Chinese motherwort (YiMuCao) aqueous ethanol extract is non-apoptotic and estrogen receptor independent on human breast cancer cells" 122 (122): 234-237, 2009

      46 Buettner C, "Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study" 100 (100): 219-227, 2006

      47 Liu J, "Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells" 378 (378): 174-178, 2009

      48 Carlsson M, "Coping in women with breast cancer in complementary and conventional care over 5 years measured by the mental adjustment to cancer scale" 11 (11): 441-447, 2005

      49 Greenlee H, "Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study" 1 : 31-, 2009

      50 Carpenter CL, "Complementary and alternative therapies among very long-term breast cancer survivors" 10 : 20-, 2008

      51 Rakovitch E, "Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death" 90 (90): 139-148, 2005

      52 Henderson JW, "Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer" 10 (10): 52-57, 2004

      53 Mueller CM, "Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer" 8 : 17-, 2008

      54 Matthews AK, "Complementary and alternative medicine use among breast cancer survivors" 13 (13): 555-562, 2007

      55 Nahleh Z, "Complementary and alternative medicine in breast cancer patients" 1 (1): 267-273, 2003

      56 Standish LJ, "Complementary and alternative medical treatment of breast cancer: a survey of licensed North American naturopathic physicians" 8 (8): 68-70, 2002

      57 Aung HH, "Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng" 59 (59): 369-374, 2007

      58 Susan G, "Breast cancer patients' perspectives on and use of complementary and alternative medicine" 4 (4): 157-169, 2006

      59 Fasching PA, "Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies" 15 (15): 1277-1284, 2007

      60 Rao MR, "Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: a randomized controlled trial" 17 (17): 1-8, 2009

      61 Liao CH, "Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo" 26 (26): 968-975, 2005

      62 Kummalue T, "Antiproliferative effect of Erycibe elliptilimba on human breast cancer cell lines" 110 (110): 439-443, 2007

      63 Feng Chen, "Antiproliferative Activities of Parthenolide and Golden Feverfew Extract Against Three Human Cancer Cell Lines" 한국식품영양과학회 9 (9): 55-61, 2006

      64 Liu H, "Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer" 591 (591): 43-51, 2008

      65 Navo MA, "An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies" 22 (22): 671-677, 2004

      66 Lee MM, "Alternative therapies used by women with breast cancer in four ethnic populations" 92 (92): 42-47, 2000

      67 Rockwell S, "Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh" 90 (90): 233-239, 2005

      68 Roscoe JA, "Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer" 29 (29): 376-384, 2005

      69 Porzio G, "Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen" 88 (88): 128-130, 2002

      70 Alem M, "Acupuncture in the rehabilitation of women after breast cancer surgery-a case series" 26 (26): 87-93, 2008

      71 Hervik J, "Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial" 10 : 7-, 2008

      72 Vickers AJ, "Acupuncture for dyspnea in advanced cancer: a randomized, placebo-controlled pilot trial" 18 : 4-5, 2005

      73 Filshie J, "Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients-audit and treatment algorithm" 23 (23): 171-180, 2005

      74 Dibble SL, "Acupressure for nausea: results of a pilot study" 27 (27): 41-47, 2000

      75 Einbond LS, "Actein inhibits the Na+-K+-ATPase and enhances the growth inhibitory effect of digitoxin on human breast cancer cells" 375 (375): 608-613, 2008

      76 Gan TJ, "A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting" 99 (99): 1070-1075, 2004

      77 J. G. Greene, "A factor analytic study of climacteric symptoms" 20 : 425-430, 1976

      78 Yang L, "23,24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and mitochondria-dependent apoptosis in human breast cancer cells (Bcap37.)" 256 (256): 267-278, 2007

      79 Korea Central Cancer Registry, "2002 Annual Report of the Korea Central Cancer Registry" Ministry of health and Welfare 2003

      80 이정희, "2000년 이후 국내 유방암에 대한 한약물의 최신 연구 경향 메타분석" 16 (16): 241-249, 2007

      81 Zhang YX, "11,11'-dideoxy-verticillin: a natural compound possessing growth factor receptor tyrosine kinase-inhibitory effect with anti-tumor activity" 16 (16): 515-524, 2005

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.38 0.38 0.4
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.39 0.43 0.545 0.13
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼